Compositions, methods and/or kits comprising a recombinant human CD38- extracellular domain
US11708418B2 · kind B2 · utility
0Cited by
2References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 1, 2018 |
| Grant date | Jul 25, 2023 |
| Priority date | — |
| Expiry date | Jun 1, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/50
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A composition that binds to an anti-CD38 antibody includes a specific sequence of a recombinant soluble form of an extracellular domain of CD38 and/or a fragment thereof that interferes with binding activity of the anti-CD38 antibody. The composition can be included in a kit for bio-monitoring research and diagnostic assays. The composition can be used to neutralize an anti-CD38 antibody in a sample and/or to select a suitable red blood cell unit for a patient treated with anti-CD38 antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.